Risk and capital management (continued)
Other risk exposures
Explanatory note
These disclosures provide information on certain elements of the Group's business activities affected by the unprecedented market events which began during the second half of 2007, the majority of which reside within Non-Core and, to a lesser extent, Global Banking & Markets ('GBM'), US Retail & Commercial and Group Treasury. For certain disclosures the information presented has been analysed into the Group's Core and Non-Core businesses.
Asset-backed securities (ABS)
The Group structures, originates, distributes and trades debt in the form of loan, bond and derivative instruments, in all major currencies and debt capital markets in North America, Western Europe, Asia and major emerging markets. The table below analyses the carrying value of the debt securities portfolio held by the Group.
|
31 March 2010 |
31 December 2009 |
|
|
£bn |
£bn |
|
|
|
|
|
Securities issued by central and local governments |
139.7 |
134.1 |
|
Asset-backed securities |
84.4 |
87.6 |
|
Securities issued by corporates, US federal agencies and other entities |
13.4 |
13.4 |
|
Securities issued by banks and building societies |
14.6 |
14.0 |
|
|
|
|
|
Total debt securities |
252.1 |
249.1 |
|
ABS are securities with an interest in an underlying pool of referenced assets. The risks and rewards of the referenced pool are passed onto investors by the issue of securities with varying seniority, by a special purpose entity.
The Group has exposures to ABS which are predominantly debt securities but can also be held in derivative form. Debt securities include residential mortgage backed securities (RMBS), commercial mortgage backed securities (CMBS), ABS collateralised debt obligations (CDOs) and collateralised loan obligations (CLOs) and other ABS. In many cases the risk on these assets is hedged by way of credit derivative protection, purchased over the specific asset or relevant ABS indices. The counterparty to some of these hedge transactions are monoline insurers.
Risk and capital management(continued)
Other risk exposures: Asset-backed securities (continued)
Asset-backed securities by geography
The table below analyses the gross and net exposures and carrying values of these asset-backed securities by geography of the underlying assets.
|
31 March 2010 |
|
31 December 2009 |
||||||||
|
US |
UK |
Other Europe |
RoW(1) |
Total |
|
US |
UK |
Other Europe |
RoW(1) |
Total |
|
£m |
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
£m |
£m |
|
|
|
|
|
|
|
|
|
|
|
|
Gross exposure:(2) |
|
|
|
|
|
|
|
|
|
|
|
RMBS: G10 governments (3) |
23,645 |
226 |
15,747 |
- |
39,618 |
|
26,693 |
314 |
16,035 |
94 |
43,136 |
RMBS: prime |
2,076 |
5,244 |
3,683 |
236 |
11,239 |
|
2,965 |
5,276 |
4,567 |
222 |
13,030 |
RMBS: non-conforming |
1,332 |
2,222 |
127 |
- |
3,681 |
|
1,341 |
2,138 |
128 |
- |
3,607 |
RMBS: sub-prime |
1,785 |
438 |
193 |
423 |
2,839 |
|
1,668 |
724 |
195 |
561 |
3,148 |
CMBS |
3,974 |
1,667 |
1,594 |
65 |
7,300 |
|
3,422 |
1,781 |
1,420 |
75 |
6,698 |
CDOs |
15,042 |
328 |
510 |
- |
15,880 |
|
12,382 |
329 |
571 |
27 |
13,309 |
CLOs |
9,967 |
114 |
1,770 |
86 |
11,937 |
|
9,092 |
166 |
2,169 |
1,173 |
12,600 |
Other ABS |
3,753 |
1,909 |
4,546 |
1,043 |
11,251 |
|
3,587 |
1,980 |
5,031 |
1,569 |
12,167 |
|
|
|
|
|
|
|
|
|
|
|
|
|
61,574 |
12,148 |
28,170 |
1,853 |
103,745 |
|
61,150 |
12,708 |
30,116 |
3,721 |
107,695 |
|
|
|
|
|
|
|
|
|
|
|
|
Carrying value: |
|
|
|
|
|
|
|
|
|
|
|
RMBS: G10 governments (3) |
24,117 |
225 |
15,236 |
- |
39,578 |
|
27,034 |
305 |
15,604 |
33 |
42,976 |
RMBS: prime |
1,819 |
4,717 |
3,441 |
237 |
10,214 |
|
2,696 |
4,583 |
4,009 |
212 |
11,500 |
RMBS: non-conforming |
996 |
2,127 |
127 |
- |
3,250 |
|
958 |
1,957 |
128 |
- |
3,043 |
RMBS: sub-prime |
956 |
263 |
163 |
401 |
1,783 |
|
977 |
314 |
146 |
387 |
1,824 |
CMBS |
3,439 |
1,328 |
1,008 |
49 |
5,824 |
|
3,237 |
1,305 |
924 |
43 |
5,509 |
CDOs |
3,523 |
122 |
370 |
- |
4,015 |
|
3,275 |
166 |
400 |
27 |
3,868 |
CLOs |
8,634 |
80 |
1,313 |
74 |
10,101 |
|
6,736 |
112 |
1,469 |
999 |
9,316 |
Other ABS |
3,250 |
1,210 |
4,316 |
844 |
9,620 |
|
2,886 |
1,124 |
4,369 |
1,187 |
9,566 |
|
|
|
|
|
|
|
|
|
|
|
|
|
46,734 |
10,072 |
25,974 |
1,605 |
84,385 |
|
47,799 |
9,866 |
27,049 |
2,888 |
87,602 |
|
|
|
|
|
|
|
|
|
|
|
|
Net exposure:(2) |
|
|
|
|
|
|
|
|
|
|
|
RMBS: G10 governments (3) |
24,117 |
225 |
15,236 |
- |
39,578 |
|
27,034 |
305 |
15,604 |
33 |
42,976 |
RMBS: prime |
1,752 |
3,782 |
2,615 |
198 |
8,347 |
|
2,436 |
3,747 |
3,018 |
172 |
9,373 |
RMBS: non-conforming |
981 |
2,127 |
127 |
- |
3,235 |
|
948 |
1,957 |
128 |
- |
3,033 |
RMBS: sub-prime |
327 |
253 |
154 |
362 |
1,096 |
|
565 |
305 |
137 |
290 |
1,297 |
CMBS |
3,073 |
1,245 |
676 |
40 |
5,034 |
|
2,245 |
1,228 |
595 |
399 |
4,467 |
CDOs |
1,012 |
75 |
345 |
- |
1,432 |
|
743 |
124 |
382 |
26 |
1,275 |
CLOs |
1,782 |
67 |
1,047 |
36 |
2,932 |
|
1,636 |
86 |
1,104 |
39 |
2,865 |
Other ABS |
2,639 |
934 |
4,281 |
663 |
8,517 |
|
2,117 |
839 |
4,331 |
1,145 |
8,432 |
|
|
|
|
|
|
|
|
|
|
|
|
|
35,683 |
8,708 |
24,481 |
1,299 |
70,171 |
|
37,724 |
8,591 |
25,299 |
2,104 |
73,718 |
For notes to this table refer to page 110.
Risk and capital management(continued)
Other risk exposures: Asset-backed securities (continued)
Asset-backed securities by rating
The table below summarises the ratings (refer to note 5 below) of ABS carrying values.
|
AAA rated |
AA- rated and above |
A- rated and above |
BBB- rated and above |
Sub- investment grade |
Not publicly rated |
Total |
|
£m |
£m |
£m |
£m |
£m |
£m |
£m |
|
|
|
|
|
|
|
|
31 March 2010 |
|
|
|
|
|
|
|
Carrying value: |
|
|
|
|
|
|
|
RMBS: G10 governments (3) |
37,116 |
2,154 |
217 |
18 |
- |
73 |
39,578 |
RMBS: prime |
7,951 |
890 |
357 |
306 |
689 |
21 |
10,214 |
RMBS: non-conforming |
1,899 |
191 |
93 |
386 |
662 |
19 |
3,250 |
RMBS: sub-prime |
561 |
238 |
263 |
72 |
636 |
13 |
1,783 |
CMBS |
3,624 |
352 |
1,029 |
380 |
213 |
226 |
5,824 |
CDOs |
778 |
672 |
351 |
564 |
1,366 |
284 |
4,015 |
CLOs |
3,189 |
3,879 |
1,350 |
666 |
95 |
922 |
10,101 |
Other ABS |
4,054 |
1,203 |
1,176 |
2,175 |
273 |
739 |
9,620 |
|
|
|
|
|
|
|
|
|
59,172 |
9,579 |
4,836 |
4,567 |
3,934 |
2,297 |
84,385 |
|
|
|
|
|
|
|
|
31 December 2009 |
|
|
|
|
|
|
|
Carrying value: |
|
|
|
|
|
|
|
RMBS: G10 governments (3) |
42,426 |
483 |
67 |
- |
- |
- |
42,976 |
RMBS: prime |
9,211 |
678 |
507 |
546 |
558 |
- |
11,500 |
RMBS: non-conforming |
1,980 |
198 |
109 |
160 |
594 |
2 |
3,043 |
RMBS: sub-prime |
578 |
121 |
306 |
87 |
579 |
153 |
1,824 |
CMBS |
3,440 |
599 |
1,022 |
299 |
147 |
2 |
5,509 |
CDOs |
616 |
943 |
254 |
944 |
849 |
262 |
3,868 |
CLOs |
2,718 |
4,365 |
607 |
260 |
636 |
730 |
9,316 |
Other ABS |
4,098 |
1,555 |
1,014 |
1,947 |
152 |
800 |
9,566 |
|
|
|
|
|
|
|
|
|
65,067 |
8,942 |
3,886 |
4,243 |
3,515 |
1,949 |
87,602 |
Notes:
(1) |
Rest of the world. |
|
(2) |
Gross exposures represent the principal amounts relating to asset-backed securities. |
|
(3) |
RMBS: G10 government securities comprises securities that are: |
|
|
(a) |
Guaranteed or effectively guaranteed by the US government, by way of its support for US federal agencies and government sponsored enterprises; |
|
(b) |
Guaranteed by the Dutch government; and |
|
(c) |
Covered bonds, referencing primarily Dutch and Spanish government-backed loans. |
(4) |
Net exposures represent the carrying value after taking account of hedge protection purchased from monoline insurers and other counterparties, but exclude the effect of counterparty credit valuation adjustments. The hedges provide credit protection of principal and interest cash flows in the event of default by the counterparty. The value of this protection is based on the underlying instrument being protected. |
|
(5) |
Credit ratings are based on those from rating agency Standard & Poor's. Moody's and Fitch have been mapped onto the Standard & Poor's scale. |
Risk and capital management (continued)
Other risk exposures: Asset-backed securities (continued)
Asset-backed securities by rating
Key points
· |
The total carrying value of asset-backed securities decreased by 4% from £87.6 billion at 31 December 2009 to £84.4 billion at 31 March 2010, principally due to net sales and maturities of £21.5 billion, partially offset by additions of £13.9 billion, exchange rate movements of £3.6 billion and fair value increases. |
||
|
|
||
· |
Life-to-date net valuation losses on ABS held at 31 March 2010, including impairment provisions, were £19.4 billion (31 December 2009 - £20.1 billion) comprising: |
||
|
|
||
|
· |
RMBS: £2.6 billion (2009 - £3.6 billion), of which £0.8 billion (2009 - £0.7 billion) was in US sub-prime and £1.6 billion (31 December 2009 - £2.3 billion) relates to European assets; |
|
|
|
||
|
· |
CMBS: £1.5 billion (31 December 2009 - £1.2 billion), primarily European assets; |
|
|
|
||
|
· |
CDOs and CLOs of £11.9 billion (31 December 2009 - £9.4 billion) and £1.8 billion (31 December 2009 - £3.3 billion) significantly all relating to US assets in the Non-Core division. Many of these assets have market hedges in place giving rise to a significant difference between the carrying value and the net exposure; and |
|
|
|
||
|
· |
Other ABS: £1.6 billion (31 December 2009 - £2.6 billion). |
|
|
|
|
|
· |
The majority of the Group's exposure to ABS was through government-backed RMBS of £39.6 billion at 31 March 2010 (31 December 2009 - £43.0 billion): |
||
|
|
||
|
· |
US government-backed securities were £24.1 billion (31 December 2009 - £27.0 billion). Due to the US government backing, explicit or implicit, in these securities, the counterparty credit risk exposure is low. This is comprised of: |
|
|
|
||
|
|
· Held-for-trading securities of £9.4 billion (31 December 2009 - £13.4 billion); increased activity in GBM Mortgage Trading allowed the opportunity to reposition and sell down US agency positions following market developments; and |
|
|
|
||
|
|
· Available-for-sale exposures of £14.7 billion (31 December 2009 - £13.6 billion) relate to liquidity portfolios held by US Retail & Commercial. |
|
|
|
|
|
|
· |
UK and other European government-backed exposures of £15.5 billion (31 December 2009 - £15.9 billion) primarily Dutch and Spanish government-backed loans and covered bonds. |
|
|
|
|
|
· |
CDOs remained broadly flat at £4.0 billion (31 December 2009 - £3.9 billion). |
||
|
|
|
|
· |
CLOs increased from £9.3 billion at 31 December 2009 to £10.1 billion at 31 March 2010, driven primarily by foreign exchange movements and improvements in prices. |
||
|
|
|
|
· |
AAA-rated assets decreased from £65.1 billion at 31 December 2009 to £59.2 billion at 31 March 2010 primarily as a result of the sell-down activity of prime and government backed securities. The US government ended its main mortgage-backed securities purchase programme in Q1 due to improved economic conditions. GBM Mortgage Trading anticipated downward pressure on prices and demand and sold off positions. |
||
Risk and capital management(continued)
Other risk exposures: Credit valuation adjustments
Credit valuation adjustments (CVA)
CVA represents an estimate of the adjustment to arrive at fair value that a market participant would make to incorporate the credit risk inherent in counterparty derivative exposures. The Group records CVA against exposures it has to these counterparties.
|
31 March 2010 |
31 December 2009 |
|
£m |
£m |
|
|
|
Monoline insurers |
3,870 |
3,796 |
CDPCs |
465 |
499 |
Other counterparties |
1,737 |
1,588 |
|
|
|
Total CVA adjustments |
6,072 |
5,883 |
Key points
· |
Total CVA held against exposures to monoline insurers and CDPCs remained stable reflecting the net effect on exposures of higher prices of underlying reference instruments being offset by the weakening of sterling against the US and Canadian dollar. The overall credit quality of the counterparties was broadly unchanged. |
|
|
· |
The increase in CVA held against exposures to other counterparties was primarily driven by rating downgrades of a number of counterparties during the quarter. |
Monoline insurers
The Group purchased protection from monolines, mainly against specific asset-backed securities. Monolines specialise in providing credit protection against the principal and interest cash flows due to the holders of debt instruments in the event of default by the debt instrument counterparty. This protection is typically held in the form of derivatives such as credit default swaps referencing underlying exposures held directly or synthetically by the Group.
The table below summarises the Group's exposure to monolines, all of which are in the Non-Core division.
|
31 March 2010 |
31 December 2009 |
|
£m |
£m |
|
|
|
Gross exposure to monolines |
6,189 |
6,170 |
Hedges with financial institutions |
(548) |
(531) |
Credit valuation adjustment |
(3,870) |
(3,796) |
|
|
|
Net exposure to monolines |
1,771 |
1,843 |
|
|
|
CVA as a % of gross exposure |
63% |
62% |
Risk and capital management (continued)
Other risk exposures: Credit valuation adjustments (continued)
Monoline insurers (continued)
Key points
· |
The exposures to monolines remained flat. Whilst the exposure in trade currency (mostly US dollar) decreased due to higher prices of underlying reference instruments, this was offset by the weakening of sterling against the US dollar. |
|
|
|
|
· |
The CVA also remained fairly stable on both a total and relative basis, with credit spread and recovery rate moves largely offsetting each other. |
|
|
|
|
· |
There have not been any changes to the methodology used to calculate the monoline CVA. However following market events in the quarter, the CVA calculation was modified to reference more conservative internally assessed recovery levels, resulting in a higher CVA reserve. |
|
|
|
|
· |
Counterparty and credit RWAs relating to risk structures incorporating gross monoline exposures decreased from £13.7 billion to £8.6 billion over the quarter. Regulatory intervention at certain monolines triggered credit events in the quarter. The exposure to these counterparties was excluded from the RWA calculations with capital deductions totalling £171 million taken instead. This, combined with an improvement in the rating of an underlying bond portfolio held by the Group to investment grade status, were the main drivers of the reduction. |
|
Risk and capital management (continued)
Other risk exposures: Credit valuation adjustments (continued)
Monoline insurers (continued)
The table below summarises monoline exposures by rating. Credit ratings are based on those from rating agencies, Standard & Poor's and Moody's. Where the ratings differ, the lower of the two is taken.
|
Notional: protected assets |
Fair value: protected assets |
Gross exposure |
CVA |
Hedges |
Net exposure |
|
£m |
£m |
£m |
£m |
£m |
£m |
|
|
|
|
|
|
|
31 March 2010 |
|
|
|
|
|
|
AA rated |
7,408 |
6,209 |
1,199 |
379 |
- |
820 |
Sub-investment grade |
13,092 |
8,102 |
4,990 |
3,491 |
548 |
951 |
|
|
|
|
|
|
|
|
20,500 |
14,311 |
6,189 |
3,870 |
548 |
1,771 |
|
|
|
|
|
|
|
Of which: |
|
|
|
|
|
|
CDOs |
2,259 |
742 |
1,517 |
1,109 |
|
|
RMBS |
85 |
72 |
13 |
1 |
|
|
CMBS |
4,450 |
2,088 |
2,362 |
1,654 |
|
|
CLOs |
10,458 |
9,193 |
1,265 |
584 |
|
|
Other ABS |
2,705 |
1,897 |
808 |
401 |
|
|
Other |
543 |
319 |
224 |
121 |
|
|
|
|
|
|
|
|
|
|
20,500 |
14,311 |
6,189 |
3,870 |
|
|
|
|
|
|
|
|
|
31 December 2009 |
|
|
|
|
|
|
AA rated |
7,143 |
5,875 |
1,268 |
378 |
- |
890 |
Sub-investment grade |
12,598 |
7,696 |
4,902 |
3,418 |
531 |
953 |
|
|
|
|
|
|
|
|
19,741 |
13,571 |
6,170 |
3,796 |
531 |
1,843 |
|
|
|
|
|
|
|
Of which: |
|
|
|
|
|
|
CDOs |
2,284 |
797 |
1,487 |
1,059 |
|
|
RMBS |
82 |
66 |
16 |
2 |
|
|
CMBS |
4,253 |
2,034 |
2,219 |
1,562 |
|
|
CLOs |
10,007 |
8,584 |
1,423 |
641 |
|
|
Other ABS |
2,606 |
1,795 |
811 |
410 |
|
|
Other |
509 |
295 |
214 |
122 |
|
|
|
|
|
|
|
|
|
|
19,741 |
13,571 |
6,170 |
3,796 |
|
|
Risk and capital management (continued)
Other risk exposures: Credit valuation adjustments (continued)
Monoline insurers (continued)
The table below analyses the net income statement effect relating to monoline exposures.
|
£m |
|
|
Credit valuation adjustment at 1 January 2010 |
(3,796) |
Credit valuation adjustment at 31 March 2010 |
(3,870) |
|
|
Increase in credit valuation adjustment |
(74) |
Net credit relating to realisation, hedges, foreign exchange and other movements |
214 |
Net debit relating to reclassified debt securities |
(90) |
|
|
Net credit to income statement (1) |
50 |
Note:
(1) |
Comprises £23 million of reversals of impairment losses and £27 million of other income relating to reclassified debt securities. Income from trading activities was nil. Net profits arose from a reduction in monoline CVA and associated foreign exchange hedges. These profits were offset by net fair value losses arising on hedges with monolines relating to reclassified debt securities. |
Key points
· |
The impact of sterling weakening against the US dollar is the primary cause of the gain arising on foreign exchange, hedges, realisations and other movements. |
|
|
|
|
· |
The net loss arising from the effect of reclassifying debt securities is due to the difference between impairment losses on these available-for-sale securities and the gains that would have been reported in the income statement if these assets had continued to be classified as held-for-trading. |
|
Cumulative net losses of £165 million relating to reclassified debt securities have not been recognised in the income statement.
Credit derivative product companies
A credit derivative product company (CDPC) is a company that sells protection against credit derivatives. CDPCs are similar to monoline insurers; however they are not regulated as insurers.
The Group has purchased credit protection from CDPCs through tranched and single name credit derivatives. The Group's exposure to CDPCs is predominantly due to tranched credit derivatives.
The table below summarises the Group's exposure to CDPCs.
|
31 March 2010 |
31 December 2009 |
|
£m |
£m |
|
|
|
Gross exposure to CDPCs |
1,243 |
1,275 |
Credit valuation adjustment |
(465) |
(499) |
|
|
|
Net exposure to CDPCs |
778 |
776 |
|
|
|
CVA as a % of gross exposure |
37% |
39% |
Risk and capital management (continued)
Other risk exposures: Credit valuation adjustments (continued)
Credit derivative product companies (continued)
Key points
· |
The exposure to CDPCs has remained stable. The exposure in trade currency (US and Canadian dollar) decreased due to a combination of trade commutations, tighter credit spreads of the underlying loans and bonds and a decrease in the relative value of senior tranches compared with the underlying reference portfolios. This decrease was offset by the weakening of sterling. |
|
|
|
|
· |
The CVA also remained fairly constant, on both a total and relative basis, reflecting general stability in the credit quality of CDPCs. |
|
|
|
|
· |
There have not been any changes to the methodology used to calculate the CDPC CVA. |
|
|
|
|
· |
Counterparty and credit RWAs relating to gross CDPC exposures increased from £7.5 billion to £7.9 billion during the quarter. Capital deductions at 31 March 2010 were £309 million (31 December 2009 - £347 million). Where the Group limits exposures to certain CDPCs with hedges, these exposures are excluded from the RWA calculations and capital deductions taken instead. |
|
|
|
|
· |
The vast majority of CDPC exposure is in Non-Core division. |
|
The table below summarises CDPC exposures by rating.
|
Notional: reference assets |
Fair value: reference assets |
Gross exposure |
CVA |
Net exposure |
|
£m |
£m |
£m |
£m |
£m |
|
|
|
|
|
|
31 March 2010 |
|
|
|
|
|
AAA rated |
1,773 |
1,752 |
21 |
6 |
15 |
Sub-investment grade |
20,411 |
19,409 |
1,002 |
379 |
623 |
Rating withdrawn |
3,916 |
3,696 |
220 |
80 |
140 |
|
|
|
|
|
|
|
26,100 |
24,857 |
1,243 |
465 |
778 |
|
|
|
|
|
|
31 December 2009 |
|
|
|
|
|
AAA rated |
1,658 |
1,637 |
21 |
5 |
16 |
BBB rated |
1,070 |
1,043 |
27 |
9 |
18 |
Sub-investment grade |
17,696 |
16,742 |
954 |
377 |
577 |
Rating withdrawn |
3,926 |
3,653 |
273 |
108 |
165 |
|
|
|
|
|
|
|
24,350 |
23,075 |
1,275 |
499 |
776 |
Risk and capital management (continued)
Other risk exposures: Credit valuation adjustments (continued)
Credit derivative product companies (continued)
The table below analyses the net income statement effect arising from CDPC exposures.
|
£m |
|
|
Credit valuation adjustment at 1 January 2010 |
(499) |
Credit valuation adjustment at 31 March 2010 |
(465) |
|
|
Decrease in credit valuation adjustment |
34 |
Net debit relating to hedges, foreign exchange and other movements |
(66) |
|
|
Net debit to income statement (income from trading activities) |
(32) |
Realised losses arising from trade commutations are the primary cause of the loss arising on foreign exchange, hedges, realisations and other movements.
CVA attributable to other counterparties
CVA for all other counterparties is calculated on a portfolio basis reflecting an estimate of the amount a third party would charge to assume the credit risk.
Expected losses are determined from market implied probability of defaults and internally assessed recovery levels. The probability of default is calculated with reference to observable credit spreads and observable recovery levels. For counterparties where observable data does not exist, the probability of default is determined from the average credit spreads and recovery levels of baskets of similarly rated entities. A weighting of 50% to 100% is applied to arrive at the expected loss. The weighting reflects portfolio churn and varies according to the counterparty credit quality.
Expected losses are applied to estimated potential future exposures which are modelled to reflect the volatility of the market factors which drive the exposures and the correlation between those factors. Potential future exposures arising from vanilla products (including interest rate and foreign exchange derivatives) are modelled jointly using the Group's core counterparty risk systems. The exposures arising from all other product types are modelled and assessed individually. The potential future exposure to counterparties is the aggregate of the exposures arising on the underlying product types.
Correlation between exposure and counterparty risk is also incorporated within the CVA calculation where this risk is considered significant. The risk primarily arises on trades with emerging market counterparties where the gross mark-to-market value of the trade, and therefore the counterparty exposure, increases as the strength of the local currency declines.
Collateral held under a credit support agreement is factored into the CVA calculation. In such cases CVA is held to the extent that residual risk remains. CVA is not held against the credit default swap protection provided by the Asset Protection Scheme where the Group has purchased protection from HM Treasury, due to the unique features of the contract.
Risk and capital management (continued)
CVA attributable to other counterparties (continued)
The table below analyses the net income statement effect arising from the change in level of CVA for all other counterparties and related trades.
|
£m |
|
|
Credit valuation adjustment at 1 January 2010 |
(1,588) |
Credit valuation adjustment at 31 March 2010 |
(1,737) |
|
|
Increase in credit valuation adjustment |
(149) |
Net credit relating to hedges, foreign exchange and other movements |
12 |
|
|
Net debit to income statement (income from trading activities) |
(137) |
Key point
· |
The increase in CVA against other counterparties was primarily driven by rating downgrades of a number of counterparties over the quarter. |
Risk and capital management (continued)
Other risk exposures: Leveraged finance
The table below analyses the Group's global markets sponsor-led leveraged finance exposures by industry and geography. The gross exposure represents the total amount of leveraged finance committed by the Group (drawn and undrawn). The net exposure represents the balance sheet carrying values of drawn leveraged finance and the total undrawn amount. The difference between gross and net exposures is principally due to the cumulative effect of impairment provisions and historic write-downs on assets prior to reclassification.
|
31 March 2010 |
|
31 December 2009 |
||||||||
|
Americas |
UK |
Other Europe |
RoW |
Total |
|
Americas |
UK |
Other Europe |
RoW |
Total |
|
£m |
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
£m |
£m |
|
|
|
|
|
|
|
|
|
|
|
|
Gross exposure: |
|
|
|
|
|
|
|
|
|
|
|
TMT (2) |
1,322 |
1,651 |
920 |
630 |
4,523 |
|
1,781 |
1,656 |
1,081 |
605 |
5,123 |
Industrial |
1,625 |
1,187 |
1,615 |
242 |
4,669 |
|
1,584 |
1,523 |
1,781 |
207 |
5,095 |
Retail |
24 |
382 |
1,161 |
64 |
1,631 |
|
17 |
476 |
1,354 |
71 |
1,918 |
Other |
231 |
1,372 |
1,101 |
225 |
2,929 |
|
244 |
1,527 |
1,168 |
191 |
3,130 |
|
|
|
|
|
|
|
|
|
|
|
|
|
3,202 |
4,592 |
4,797 |
1,161 |
13,752 |
|
3,626 |
5,182 |
5,384 |
1,074 |
15,266 |
|
|
|
|
|
|
|
|
|
|
|
|
Net exposure: |
|
|
|
|
|
|
|
|
|
|
|
TMT (2) |
1,122 |
1,533 |
911 |
528 |
4,094 |
|
1,502 |
1,532 |
1,045 |
590 |
4,669 |
Industrial |
383 |
1,079 |
1,440 |
233 |
3,135 |
|
524 |
973 |
1,594 |
205 |
3,296 |
Retail |
24 |
348 |
1,098 |
61 |
1,531 |
|
17 |
445 |
1,282 |
68 |
1,812 |
Other |
228 |
1,303 |
1,092 |
226 |
2,849 |
|
244 |
1,461 |
1,147 |
191 |
3,043 |
|
|
|
|
|
|
|
|
|
|
|
|
|
1,757 |
4,263 |
4,541 |
1,048 |
11,609 |
|
2,287 |
4,411 |
5,068 |
1,054 |
12,820 |
|
|
|
|
|
|
|
|
|
|
|
|
Of which: |
|
|
|
|
|
|
|
|
|
|
|
Drawn |
1,377 |
3,735 |
3,680 |
895 |
9,687 |
|
1,944 |
3,737 |
3,909 |
950 |
10,540 |
Undrawn |
380 |
528 |
861 |
153 |
1,922 |
|
343 |
674 |
1,159 |
104 |
2,280 |
|
|
|
|
|
|
|
|
|
|
|
|
|
1,757 |
4,263 |
4,541 |
1,048 |
11,609 |
|
2,287 |
4,411 |
5,068 |
1,054 |
12,820 |
Notes:
(1) |
All the above exposures are in the Non-Core division. |
(2) |
Telecommunications, Media and Technology. |
Key points
· |
The Group's sterling exposure has reduced as a result of sales and restructurings of £0.9 billion and £0.4 billion of repayments and re-financings. These reductions were partially offset by the strengthening of the US dollar and euro against sterling during the period. |
|
|
|
|
· |
Credit impairments and write-offs during the quarter were £198 million. |
|
Not included in the table above are: |
||
· |
UK Corporate leveraged finance net exposures of £7.5 billion at 31 March 2010 (31 December 2009 - £7.1 billion), mainly to the retail and industrial sectors. |
|
|
|
|
· |
Ulster Bank leveraged finance net exposures of £0.6 billion at 31 March 2010 and 31 December 2009. |
|
Risk and capital management (continued)
Other risk exposures: Special purpose entities
For background on the Group's involvement with securitisations and special purpose entities, refer to the Business review section of the 2009 Annual Report and Accounts.
The table below analyses the asset categories together with the carrying amount of the assets and associated liabilities for those securitisations and other asset transfers, other than conduits (discussed below), where the assets continue to be recorded on the Group's balance sheet.
|
31 March 2010 |
|
31 December 2009 |
||
|
Assets |
Liabilities |
|
Assets |
Liabilities |
|
£m |
£m |
|
£m |
£m |
|
|
|
|
|
|
Residential mortgages |
68,820 |
16,031 |
|
69,927 |
15,937 |
Credit card receivables |
2,666 |
1,614 |
|
2,975 |
1,592 |
Other loans |
36,261 |
1,000 |
|
36,448 |
1,010 |
Finance lease receivables |
613 |
613 |
|
597 |
597 |
Conduits
The total assets held by Group-sponsored conduits were £24.1 billion at 31 March 2010 (31 December 2009 - £27.4 billion). Liquidity commitments from the Group to the conduit exceed the nominal amount of assets funded by the conduit as liquidity commitments are sized to cover the funding cost of the related assets.
The table below analyses the exposure to conduits which are consolidated by the Group.
|
31 March 2010 |
|
31 December 2009 |
||||
|
Core |
Non-Core |
Total |
|
Core |
Non-Core |
Total |
|
£m |
£m |
£m |
|
£m |
£m |
£m |
|
|
|
|
|
|
|
|
Total assets held by the conduits |
20,256 |
3,862 |
24,118 |
|
23,409 |
3,957 |
27,366 |
|
|
|
|
|
|
|
|
Commercial paper issued (1) |
19,902 |
2,830 |
22,732 |
|
22,644 |
2,939 |
25,583 |
|
|
|
|
|
|
|
|
Liquidity and credit enhancements: |
|
|
|
|
|
|
|
Deal specific liquidity: |
|
|
|
|
|
|
|
- drawn |
319 |
1,072 |
1,391 |
|
738 |
1,059 |
1,797 |
- undrawn |
26,426 |
3,573 |
29,999 |
|
28,628 |
3,852 |
32,480 |
PWCE (2) |
1,129 |
359 |
1,488 |
|
1,167 |
341 |
1,508 |
|
|
|
|
|
|
|
|
|
27,874 |
5,004 |
32,878 |
|
30,533 |
5,252 |
35,785 |
|
|
|
|
|
|
|
|
Maximum exposure to loss (3) |
26,745 |
4,645 |
31,390 |
|
29,365 |
4,911 |
34,276 |
Notes:
(1) |
Excludes own asset conduits established for contingent funding as it does not have any outstanding commercial paper. |
(2) |
Programme-wide credit enhancement. |
(3) |
Maximum exposure to loss is determined as the Group's total liquidity commitments to the conduits and additionally programme-wide credit support which would absorb first loss on transactions where liquidity support is provided by a third party. Third party maximum exposure to loss is reduced by repo trades conducted with an external counterparty. |
Risk and capital management (continued)
Other risk exposures: Special purpose entities (continued)
The Group also extends liquidity commitments to multi-seller conduits sponsored by other banks, but typically does not consolidate these entities as it does not retain the majority of risks and rewards.
The table below analyses the Group's exposure from third-party conduits.
|
31 March 2010 |
|
31 December 2009 |
||||
|
Core |
Non-Core |
Total |
|
Core |
Non-Core |
Total |
|
£m |
£m |
£m |
|
£m |
£m |
£m |
|
|
|
|
|
|
|
|
Liquidity and credit enhancements: |
|
|
|
|
|
|
|
Deal specific liquidity: |
|
|
|
|
|
|
|
- drawn |
232 |
128 |
360 |
|
223 |
120 |
343 |
- undrawn |
219 |
38 |
257 |
|
206 |
38 |
244 |
|
|
|
|
|
|
|
|
|
451 |
166 |
617 |
|
429 |
158 |
587 |
|
|
|
|
|
|
|
|
Maximum exposure to loss |
451 |
166 |
617 |
|
429 |
158 |
587 |
Key points
· |
During the quarter both multi-seller and own asset conduit assets have been reduced in line with the wider Group balance sheet management. |
|
|
|
|
· |
Multi-seller conduits account for 43% of total liquidity and credit enhancements committed by the Group, unchanged from the year end position. |
|
|
|
|
· |
The Group's own asset conduit programme was established to diversify the Group's funding sources, including access to the Bank of England's open market operations, with committed liquidity of US$40.8 billion. |
|